Aguilar-Guisado, Manuela <br/><br/>
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.  [electronic resource] 

 -  The Lancet. Haematology  Dec 2017 
 - e573-e583 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2352-3026 
<br/><br/><label>Standard No.: </label>10.1016/S2352-3026(17)30211-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Infective Agents--adverse effects<br/>Bacterial Infections--drug therapy<br/>Diarrhea--etiology<br/>Drug Therapy, Combination<br/>Febrile Neutropenia--complications<br/>Female<br/>Hematologic Neoplasms--complications<br/>Humans<br/>Male<br/>Middle Aged<br/>Mycoses--drug therapy<br/>Nausea--etiology<br/>Risk<br/>Treatment Outcome